S&P 500 7,757.17 +0.58%
Nasdaq 26,702.86 +1.05%
S&P/TSX 36,324.99 +0.60%
Apple 343.99 +1.32%
Nvidia 221.97 +2.54%
Microsoft 532.95 +0.20%
Shopify 244.93 +0.38%
Royal Bank 283.62 +1.23%
CAD/USD 0.7119 +0.14%
AFTER HRS · 18:30 ET
Market ClerkRecap
Wed Oct 21 · after hours2 signals today106 insider buys this week · $305.5MCIRO short report next: Oct 31The week ahead

GILD

GILEAD SCIENCES, INC.
NASDAQ · HEALTH CARE · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
156.51
+3.44 +2.25%
USD · Oct 20, 07:40 p.m. ET

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $194.1BP/E —DIV YIELD 2.06%FCF YIELD 6.67%REV TTM $30.5B +5.5%NET INCOME −$3.2B −151.3%NET DEBT $20.8B52W 117.88 – 157.37NEXT EARNINGS Oct 29SEC XBRL · TTM TO Invalid Date

What GILD had to tell the SEC

FORM 8-K · TWO YEARS · MOST RECENT FIRST
No 8-K filings from GILD on record yet. The events worker reads new filings each morning; older ones appear as the sweep reaches them.

Items read from each filing’s EDGAR index page; labels are ours. Every tracked company’s 8-Ks, most serious first.

Watch GILD. Know when insiders buy.
One email the day a filing lands. Free.